| Patents for C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005) |
|---|
| 05/11/2010 | US7713980 Antitumor agents; anticancer agents |
| 05/11/2010 | US7713963 Acylated indanyl amines and their use as pharmaceuticals |
| 05/11/2010 | US7713961 Substituted 1,2-ethylenediamines, methods for preparing them and uses thereof |
| 05/11/2010 | CA2462110C Phenyl-piperazine derivatives as serotonin reuptake inhibitors |
| 05/11/2010 | CA2431091C Organic reactions with co generating materials |
| 05/06/2010 | WO2010050779A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same |
| 05/06/2010 | WO2010050436A1 Piperidine derivative, piperazine derivative and agent for treatment of disease involving central nervous system disorders |
| 05/06/2010 | WO2010049768A1 Acrylamido derivatives useful as inhibitors of the mitochondrial permeability transition |
| 05/06/2010 | WO2010048715A1 Gemini surfactants |
| 05/06/2010 | US20100113770 O-substituted hydroxyaryl derivatives |
| 05/06/2010 | US20100113449 Fused heterocyclic compounds as ion channel modulators |
| 05/06/2010 | US20100112708 Methods and Mixtures Pertaining to Analyte Determination Using Electrophilic Labeling Reagents |
| 05/06/2010 | CA2779178A1 Analgesic that binds filamin a |
| 05/06/2010 | CA2741697A1 Gemini surfactants |
| 05/06/2010 | CA2741658A1 Piperidine derivative, piperazine derivative and agent for treatment of disease involving central nervous system disorders |
| 05/06/2010 | CA2741433A1 Acrylamido derivatives useful as inhibitors of the mitochondrial permeability transition |
| 05/05/2010 | EP1799627B1 Iron or cobalt-catalyzed carbon-carbon coupling reaction of aryls, alkenes and alkines with copper reagents |
| 05/05/2010 | CN1983490B Dynamic molecular-based electronic device and its operation |
| 05/05/2010 | CN1764661B Benzenesulphonamide derivatives, method for production and use thereof for treatment of pain. |
| 05/05/2010 | CN1630629B 酯化合物及其医药用途 Ester compounds and pharmaceutical use |
| 05/04/2010 | USRE41315 Modulators of dopamine neurotransmission |
| 05/04/2010 | US7709640 Inhibitors of phosphorylation of platelet derived growth factor receptor |
| 05/04/2010 | US7709487 Sulfonyl-derivatives as novel inhibitors of histone deacetylase |
| 05/04/2010 | US7709485 IL-8 receptor antagonists |
| 05/04/2010 | US7709484 1-((2R,5S)-5-Benzyl-2-naphthalen-2-ylmethyl-piperazin-1-yl)-3-(2,4-dichloro-phenyl)-propan-1-one; melanocortin receptor-associated disorder such as cachexia, obesity, erectile dysfunction or female sexual dysfunction |
| 05/04/2010 | US7709478 Acylated 6,7,8,9-tetrahydro-5H-benzocycloheptenyl amines and their use as pharmaceutical agents |
| 05/04/2010 | US7709466 Pyridazinone derivatives, methods for their production and their use as pharmaceuticals |
| 04/29/2010 | WO2010047335A1 Benzene compound |
| 04/29/2010 | WO2010046360A1 Process for the preparation of substantially optically pure repaglinide and precursors thereof |
| 04/29/2010 | US20100105900 Inhibitors of carnitine palmitoyltransferase and treating cancer |
| 04/29/2010 | US20100105894 Cyclopropane compounds and pharmaceutical use thereof |
| 04/29/2010 | US20100105686 Phenylsulfamoyl benzamide derivatives as bradykinin antagonists |
| 04/29/2010 | US20100105682 Cyclopropyl-piperazine compounds as calcium channel blockers |
| 04/28/2010 | EP2179984A1 Acrylamido derivatives useful as inhibitors of the mitochondrial permeability transition |
| 04/28/2010 | EP2178879A2 6-cycloamino-s-(pyridazin-4-yl)imidazo[1,2-b]-pyridazine and derivatives thereof preparation and therapeutic application thereof |
| 04/28/2010 | CN1795183B Hydroxyamidine and hydroxyguanidine compounds as urokinase inhibitors |
| 04/28/2010 | CN1747929B Inhibitors of the binding of chemokines i-tac or sdf-1 to the ccxckr2 receptor |
| 04/28/2010 | CN1658855B O-substituted hydroxyaryl derivatives |
| 04/28/2010 | CN1642638B Catalysts and method for the production of amines |
| 04/28/2010 | CN101698649A Short-acting hypnotizing and calming compound used for anesthetization |
| 04/27/2010 | US7705145 reduction of 4-methoxy-5-(3-morpholinopropoxy)-2-nitrobenzonitrile to give 2-amino-4-methoxy-5-(3-morpholinopropoxy)benzonitrile, hydration of intermediated to form 2-amino-4-methoxy-5-(3-morpholinopropoxy)benzamide; cyclization |
| 04/27/2010 | US7705053 Benzamide derivative |
| 04/27/2010 | US7705003 trans-N-{4-[2-[4-(indan-4-yl)-piperazin-1-yl]-ethyl]-cyclohexyl}-acetamidethe; highest affinity to D3 receptor; no disadvantages of each individual receptor action; antidepressant, anxiolitic agent, cognition activator; psychoses, schizophrenia, drug (alcohol, cocaine and nicotine) abuse, hyperactivity |
| 04/27/2010 | US7705002 Na channel and Ca channel antagonists; potentiation; side effects reduction; pains, epilepsy, neurodegenerative disorders, psychiatric disorders,movement disorders, neuroendocrine disorders etc.; 2-hydroxy-1-[4-[3-(2-hydroxyphenyl)phenyl]piperazin-1-yl]-4-methyl-pentan-1-one; |
| 04/27/2010 | US7704998 Sulfonyl-derivatives as novel inhibitors or histone deacetylase |
| 04/27/2010 | CA2437524C Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives |
| 04/27/2010 | CA2345118C Substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity |
| 04/27/2010 | CA2338968C Glucocorticoid-selective agents |
| 04/22/2010 | WO2010044940A2 2,5-linked polyfluorenes for optoelectronic devices |
| 04/22/2010 | WO2010043976A2 Highly pure ranolazine or a pharmaceutically acceptable salt thereof |
| 04/22/2010 | WO2010043721A1 Oxidase inhibitors and their use |
| 04/22/2010 | WO2010043584A1 Salicylic acid derivatives being farnesyl pyrophosphate synthase activity inhibitors |
| 04/22/2010 | WO2010043218A2 Tetrathiol ligands, metal complexes, conjugates, and kits, the use thereof in nuclear medicine diagnostics and endoradionuclide therapy, and method for producing the tetrathiol ligands and metal complexes |
| 04/22/2010 | WO2010043000A1 S1p receptors modulators and their use thereof |
| 04/22/2010 | US20100099868 Biological Buffers with Wide Buffering Ranges |
| 04/22/2010 | CA2740484A1 S1p receptors modulators and their use thereof |
| 04/22/2010 | CA2736206A1 Salicylic acid derivatives being farnesyl pyrophosphate synthase activity inhibitors |
| 04/21/2010 | EP2177505A1 Bicyclic acylguanidine derivative |
| 04/21/2010 | EP2177502A1 Compounds and their use |
| 04/21/2010 | EP2177221A1 Process for the preparation of substantially optically pure Repaglinide and precursors thereof |
| 04/21/2010 | EP2175856A2 Novel process for preparing highly pure levocetirizine and salts thereof |
| 04/21/2010 | EP2041093B1 Piperazinyl derivatives useful in the treatment of gpr38 receptor mediated diseases |
| 04/21/2010 | EP1272175B1 N,n'-diaryl guanidines as il-8 receptor antagonists |
| 04/21/2010 | CN101696195A Method for purifying piperidine |
| 04/20/2010 | US7700775 Drug delivery |
| 04/20/2010 | US7700769 cyclin dependent kinase inhibitors |
| 04/20/2010 | US7700655 Antiallergic agents |
| 04/20/2010 | US7700617 Salt of naphthyridine carboxylic acid derivative |
| 04/20/2010 | US7700600 Using vanoxerine type medicant; blocking calcium channel current |
| 04/20/2010 | US7700597 For treating diseases or conditions mediated by cannabinoid receptors, such as metabolic syndrome and obesity, neuroinflammatory disorders, cognitive disorders and psychosis, addiction (smoking cessation), gastrointestinal disorders, and cardiovascular conditions |
| 04/20/2010 | US7700593 Imidazo- and triazolo-pyridine compounds and methods of use thereof |
| 04/20/2010 | US7700587 Haloperidol analogs |
| 04/20/2010 | US7700586 Arylsulfonamide derivatives for use as ccr3 antagonists in the treatment of inflammatory and immunological disorders |
| 04/20/2010 | CA2418744C Novel aminocyclohexane derivatives |
| 04/20/2010 | CA2348741C Nitrosasted and nitrosylated nonsteroidal antiinflammatory compounds, comositions and methods of use |
| 04/20/2010 | CA2319680C Compounds and compositions for delivering active agents |
| 04/20/2010 | CA2279331C Compounds and compositions for delivering active agents |
| 04/15/2010 | WO2010042867A2 Activators of human pyruvate kinase |
| 04/15/2010 | WO2010042165A2 Methods of making cyclic, n-amino functional triamines |
| 04/15/2010 | WO2010042159A1 Methods of making cyclic, n-amino functional triamines |
| 04/15/2010 | WO2010041748A1 Fluorene compound and use thereof for medical purposes |
| 04/15/2010 | WO2010041618A1 Pharmaceutical composition for prevention or treatment of hearing loss and secondary symptoms of hearing loss |
| 04/15/2010 | WO2010040843A2 Dibenzocycloheptanone derivatives and pharmaceutical agents containing said compounds |
| 04/15/2010 | WO2010040630A1 Raft polymers and raft reagents |
| 04/15/2010 | WO2010040315A1 The 1-butyl-2-hydroxyaralkyl piperazine derivatives and the uses as anti-depression medicine thereof |
| 04/15/2010 | WO2009152906A3 Use of ionic liquids with tetracyanoborate anions as a solvent for extraction of alcohols from aqueous solutions |
| 04/15/2010 | US20100093985 Use of at least one cytosolic phospholipase a2 inhibitor as a medicine for symptomatic treatment of mucoviscidosis |
| 04/15/2010 | US20100093855 Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes, hyperlipidemia and hyperuricemia |
| 04/15/2010 | US20100093735 Cytokine inhibitors |
| 04/15/2010 | US20100093734 Cytokine inhibitors |
| 04/15/2010 | US20100093733 Amide and urea derivatives for the treatment of metabolic diseases |
| 04/15/2010 | US20100093713 Beta-carbolines useful for treating inflammatory disease |
| 04/15/2010 | US20100093708 Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use |
| 04/15/2010 | US20100093671 Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use |
| 04/15/2010 | CA2740148A1 Activators of human pyruvate kinase |
| 04/15/2010 | CA2739877A1 The 1-butyl-2-hydroxyaralkyl piperazine derivatives and the uses as anti-depression medicine thereof |
| 04/14/2010 | EP2173730A1 Novel compounds 951: a biphenyloxypropanoic acid as crth2 modulator and intermediates |
| 04/14/2010 | EP1694410B1 Cyclopropane derivatives and pharmaceutical use thereof |
| 04/14/2010 | EP1627871B1 Cyclic aminophenyl sulfamate derivative |
| 04/14/2010 | EP1551799B1 Cyclohexyl sulphones as gamma-secretase inhibitors |